Nexcida Therapeutics

About:

Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections.

Description:

Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections. The company is led by an outstanding team of proven anti-infectives drug developers and is committed to addressing the emerging threat of drug-resistant bacteria. Nexcida Therapeutics was founded in 2014 and is based in Menlo Park, California.

Total Funding Amount:

$2.75M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2014-01-01

Founders:

Number of Employees:

Last Funding Date:

2015-06-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai